CoChat

Tumor-induced loss of mural Connexin 43 gap junction activity promotes endothelial proliferation

Open access
Choudhary, Mayur, Naczki, Christine, Chen, Wenhong, Barlow, Keith D., Case, L. Douglas, Metheny-Barlow, Linda J. · 2015 · BMC Cancer

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

BACKGROUND: Proper functional association between mural cells and endothelial cells (EC) causes EC of blood vessels to become quiescent. Mural cells on tumor vessels exhibit decreased attachment to EC, which allows vessels to be unstable and proliferative. The mechanisms by which tumors prevent proper association between mural cells and EC are not well understood. Since gap junctions (GJ) play an important role in cell-cell contact and communication, we investigated whether loss of GJ plays a role in tumor-induced mural cell dissociation. METHODS: Mural cell regulation of endothelial proliferation was assessed by direct co-culture assays of fluorescently labeled cells quantified by flow cytometry or plate reader. Gap junction function was assessed by parachute assay. Connexin 43 (Cx43) protein in mural cells exposed to conditioned media from cancer cells was assessed by Western and confocal microscopy; mRNA levels were assessed by quantitative real-time PCR. Expression vectors or siRNA were utilized to overexpress or knock down Cx43. Tumor growth and angiogenesis was assessed in mouse hosts deficient for Cx43. RESULTS: Using parachute dye transfer assay, we demonstrate that media conditioned by MDA-MB-231 breast cancer cells diminishes GJ communication between mural cells (vascular smooth muscle cells, vSMC) and EC. Both protein and mRNA of the GJ component Connexin 43 (Cx43) are downregulated in mural cells by tumor-conditioned media; media from non-tumorigenic MCF10A cells had no effect. Loss of GJ communication by Cx43 siRNA knockdown, treatment with blocking peptide, or exposure to tumor-conditioned media diminishes the ability of mural cells to inhibit EC proliferation in co-culture assays, while overexpression of Cx43 in vSMC restores GJ and endothelial inhibition. Breast tumor cells implanted into mice heterozygous for Cx43 show no changes in tumor growth, but exhibit significantly increased tumor vascularization determined by CD31 staining, along with decreased mural cell support detected by NG2 staining. CONCLUSIONS: Our data indicate that i) functional Cx43 is required for mural cell-induced endothelial quiescence, and ii) downregulation of Cx43 GJ by tumors frees endothelium to respond to angiogenic cues. These data define a novel and important role for maintained Cx43 function in regulation of vessel quiescence, and suggest its loss may contribute to pathological tumor angiogenesis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12885-015-1420-9

Cites

Statistics

Figures

Fig. 1 Breast tumors release endothelial cells from mural cell inhibition and downregulate mural cell Cx43. vSMC and GFP-HUVEC a or HBVP and GFP-HBMEC b were plated alone or in co-culture overnight in normal growth media, then cultured in control media (‘Mock’) or media conditioned by MDA-MB-231 cells (‘231’) or MCF10A cells (‘10A’). At the end of four days, fluorescence was quantified. Data shown are representative of three experiments performed in duplicate or triplicate (**p < 0.01; ***p = 0.001). c Western analysis of indicated endothelial or mural cells starved overnight then stimulated for 24 h with control media (‘Mock’) or media conditioned by tumor cells (‘231’) and are representative of at least 2–4 replicate experiments for each cell line. d Quantification of Cx43 protein levels compared in vSMC and HBVP treated for 24 h with media conditioned by MDA-MB-231 tumor cells or control mock media normalized to tubulin levels (n = 6 different vSMC donor lots; *** p < 0.001; for HBVP n = 3 independent experiments with 2 different donor lots; *p < 0.05)
Fig. 1 Breast tumors release endothelial cells from mural cell inhibition and downregulate mural cell Cx43. vSMC and GFP-HUVEC a or HBVP and GFP-HBMEC b were plated alone or in co-culture overnight in normal growth media, then cultured in control media (‘Mock’) or media conditioned by MDA-MB-231 cells (‘231’) or MCF10A cells (‘10A’). At the end of four days, fluorescence was quantified. Data shown are representative of three experiments performed in duplicate or triplicate (**p < 0.01; ***p = 0.001). c Western analysis of indicated endothelial or mural cells starved overnight then stimulated for 24 h with control media (‘Mock’) or media conditioned by tumor cells (‘231’) and are representative of at least 2–4 replicate experiments for each cell line. d Quantification of Cx43 protein levels compared in vSMC and HBVP treated for 24 h with media conditioned by MDA-MB-231 tumor cells or control mock media normalized to tubulin levels (n = 6 different vSMC donor lots; *** p < 0.001; for HBVP n = 3 independent experiments with 2 different donor lots; *p < 0.05)CC BY · PubMed Central
Fig. 2 Gap junction communication between mural cells and endothelial cells requires mural cell Cx43 and is decreased by tumor cells. Untransfected vSMC or vSMC nucleofected with non-targeting (‘siNT’) or Connexin43-specific (‘siCx43’) siRNA were treated with control (‘Mock’) or media conditioned by MDA-MB-231 cells (‘231 CM’), loaded with calcein-AM, and plated onto PKH26-labeled HUVEC. Dye transfer from vSMC to HUVEC was quantified using flow cytometry. a. Representative flow cytometry dot plots showing dye transfer as percentage of double-labeled cells in upper right quadrant. b. Ratio of dye transfer as calculated in Materials and Methods. Data represent the mean of four to five independent experiments performed in triplicate +/−s.e.m. (duplicate for 18-GA); ***p < 0.001. c. Western analysis of Connexin 43 in vSMC samples incubated in parallel with experiment from A. d. vSMC and GFP-HUVEC were plated in co-culture for 72 h as in ‘Methods’, then stimulated for 24 h with control media (‘Mock’) or media conditioned by MDA-MB-231 cells (‘231 CM’), and the number of heterocellular Cx43-expressing junctions (red) extending between endothelial cells (green) and mural cells quantified by confocal Z-stack analysis. Top panel, representative confocal images; inset, magnification of z-stack image of Cx43 gap junction. Bottom panel, quantification of Cx43-positive heterotypic gap junctions as seen in top panel. Data represent the quantification from paired cells over three experiments (n = 46–48 cell pairs each condition)+/−s.e.m. (*p < 0.05)
Fig. 2 Gap junction communication between mural cells and endothelial cells requires mural cell Cx43 and is decreased by tumor cells. Untransfected vSMC or vSMC nucleofected with non-targeting (‘siNT’) or Connexin43-specific (‘siCx43’) siRNA were treated with control (‘Mock’) or media conditioned by MDA-MB-231 cells (‘231 CM’), loaded with calcein-AM, and plated onto PKH26-labeled HUVEC. Dye transfer from vSMC to HUVEC was quantified using flow cytometry. a. Representative flow cytometry dot plots showing dye transfer as percentage of double-labeled cells in upper right quadrant. b. Ratio of dye transfer as calculated in Materials and Methods. Data represent the mean of four to five independent experiments performed in triplicate +/−s.e.m. (duplicate for 18-GA); ***p < 0.001. c. Western analysis of Connexin 43 in vSMC samples incubated in parallel with experiment from A. d. vSMC and GFP-HUVEC were plated in co-culture for 72 h as in ‘Methods’, then stimulated for 24 h with control media (‘Mock’) or media conditioned by MDA-MB-231 cells (‘231 CM’), and the number of heterocellular Cx43-expressing junctions (red) extending between endothelial cells (green) and mural cells quantified by confocal Z-stack analysis. Top panel, representative confocal images; inset, magnification of z-stack image of Cx43 gap junction. Bottom panel, quantification of Cx43-positive heterotypic gap junctions as seen in top panel. Data represent the quantification from paired cells over three experiments (n = 46–48 cell pairs each condition)+/−s.e.m. (*p < 0.05)CC BY · PubMed Central
Fig. 3 Breast tumor downregulation of Cx43 in vSMC is time- and dose- dependent. a, b. vSMC were stimulated for 24 h with media conditioned by the indicated cell line and lysates analyzed for Cx43 levels. Bottom panels represent quantification of an = 4 experiments, bn = 5 experiments, *p < 0.05; **p < 0.01; ***p < 0.001. c. vSMC were treated for the indicated time with media conditioned by MDA-MB-231 cells and lysates analyzed by Western. Data representative of two to four experiments. d vSMC were treated for 24 h with media conditioned by varying dilutions of MDA-MB-231 cell CM. Bottom panel represents quantification from 3 independent experiments. e. mRNA was isolated and subjected to quantitative PCR analysis. Data were normalized to GAPDH levels and fold change compared to Mock; data represent the mean of three independent experiments each performed in technical triplicate (*p < 0.05; **p < 0.01)
Fig. 3 Breast tumor downregulation of Cx43 in vSMC is time- and dose- dependent. a, b. vSMC were stimulated for 24 h with media conditioned by the indicated cell line and lysates analyzed for Cx43 levels. Bottom panels represent quantification of an = 4 experiments, bn = 5 experiments, *p < 0.05; **p < 0.01; ***p < 0.001. c. vSMC were treated for the indicated time with media conditioned by MDA-MB-231 cells and lysates analyzed by Western. Data representative of two to four experiments. d vSMC were treated for 24 h with media conditioned by varying dilutions of MDA-MB-231 cell CM. Bottom panel represents quantification from 3 independent experiments. e. mRNA was isolated and subjected to quantitative PCR analysis. Data were normalized to GAPDH levels and fold change compared to Mock; data represent the mean of three independent experiments each performed in technical triplicate (*p < 0.05; **p < 0.01)CC BY · PubMed Central
Fig. 4 Mural cell inhibition of endothelial cell proliferation requires mural cell Cx43 and GJ communication. Labeled mural cells (a and b, C3H 10 T1/2 cells, or c and d, vSMC) nucleofected with control non-targeting or Cx43 siRNA were cultured with labeled HUVEC and effects on HUVEC proliferation assessed by cell counting followed by flow cytometry at indicated days. a. Pooled data from three independent experiments performed in triplicate using HUVEC from two different donors. (*p < 0.05). b. Western analysis of Cx43 expression from representative experiment from A. c. Pooled data from five independent experiments performed in triplicate using vSMC from three different donors and HUVEC from two different donors (*p < 0.05; *** p = 0.001). d. Western analysis of Cx43 expression from representative experiment from C. e. Labeled mural cells were cultured with GFP-HUVEC for four days in the presence of GAP26 blocking peptide or control scrambled peptide and effects on HUVEC proliferation assessed as in A. Data shown are from a representative of two experiment performed in triplicate (*p < 0.05)
Fig. 4 Mural cell inhibition of endothelial cell proliferation requires mural cell Cx43 and GJ communication. Labeled mural cells (a and b, C3H 10 T1/2 cells, or c and d, vSMC) nucleofected with control non-targeting or Cx43 siRNA were cultured with labeled HUVEC and effects on HUVEC proliferation assessed by cell counting followed by flow cytometry at indicated days. a. Pooled data from three independent experiments performed in triplicate using HUVEC from two different donors. (*p < 0.05). b. Western analysis of Cx43 expression from representative experiment from A. c. Pooled data from five independent experiments performed in triplicate using vSMC from three different donors and HUVEC from two different donors (*p < 0.05; *** p = 0.001). d. Western analysis of Cx43 expression from representative experiment from C. e. Labeled mural cells were cultured with GFP-HUVEC for four days in the presence of GAP26 blocking peptide or control scrambled peptide and effects on HUVEC proliferation assessed as in A. Data shown are from a representative of two experiment performed in triplicate (*p < 0.05)CC BY · PubMed Central
Fig. 5 Breast tumor cells inhibit GJ activity and release endothelial cells from mural cell-induced growth inhibition in a Cx43-dependent manner. a. vSMC nucleofected with control vector or vector overexpressing wild-type Cx43 were treated with control media (‘Mock’) or MDA-MB-231 conditioned media (‘231 CM’), loaded with calcein-AM, and plated onto HUVEC labeled with PHK26. Dye transfer from vSMC to HUVEC was quantified using flow cytometry (*p < 0.05; ns, not significant). Data represent the mean+/− s.e.m. of three experiments performed in triplicate. b. vSMC nucleofected with control vector or vector overexpressing wild-type Cx43 were plated with GFP-HUVEC in the presence of control media or media conditioned for 24 h by 231 cells. Fluorescence was analyzed after four days as in Fig. 1. Data represent the mean+/−s.e.m. of four experiments with two vSMC donors performed in triplicate or duplicate.(*p < 0.05; **p < 0.01; ns, not significant). c. Western analysis of vSMC nucleofected with control vector or Cx43 overexpression vector and exposed to MDA-MB-231 conditioned media for 24 h
Fig. 5 Breast tumor cells inhibit GJ activity and release endothelial cells from mural cell-induced growth inhibition in a Cx43-dependent manner. a. vSMC nucleofected with control vector or vector overexpressing wild-type Cx43 were treated with control media (‘Mock’) or MDA-MB-231 conditioned media (‘231 CM’), loaded with calcein-AM, and plated onto HUVEC labeled with PHK26. Dye transfer from vSMC to HUVEC was quantified using flow cytometry (*p < 0.05; ns, not significant). Data represent the mean+/− s.e.m. of three experiments performed in triplicate. b. vSMC nucleofected with control vector or vector overexpressing wild-type Cx43 were plated with GFP-HUVEC in the presence of control media or media conditioned for 24 h by 231 cells. Fluorescence was analyzed after four days as in Fig. 1. Data represent the mean+/−s.e.m. of four experiments with two vSMC donors performed in triplicate or duplicate.(*p < 0.05; **p < 0.01; ns, not significant). c. Western analysis of vSMC nucleofected with control vector or Cx43 overexpression vector and exposed to MDA-MB-231 conditioned media for 24 hCC BY · PubMed Central
Fig. 6 Cx43 deficiency results in enhanced angiogenesis and decreased stabilization but does not affect tumor growth. Eo771 cells were implanted into the mammary fat pad of female mice that were wild-type (‘WT’) or heterozygous (‘Cx43’) for Cx43. a. Representative tumor sections stained for CD31 (red) shown at 20x. Bottom panel represents quantification of average CD31+ area per field (n = 8 tumors/group). *p < 0.05. b. Representative tumor sections stained for NG2 (green) and CD31 (red). Bottom panel represents quantification of relative area of NG2 positivity of CD31 positive vessels (5 fields/tumor, n = 3 tumors per group); **p < 0.01. c. Tumors were measured using calipers and volume estimated using the formula (((L + W)/2)^3)/2. d. Tumor mass was determined at the time of sacrifice (n = 10-11)
Fig. 6 Cx43 deficiency results in enhanced angiogenesis and decreased stabilization but does not affect tumor growth. Eo771 cells were implanted into the mammary fat pad of female mice that were wild-type (‘WT’) or heterozygous (‘Cx43’) for Cx43. a. Representative tumor sections stained for CD31 (red) shown at 20x. Bottom panel represents quantification of average CD31+ area per field (n = 8 tumors/group). *p < 0.05. b. Representative tumor sections stained for NG2 (green) and CD31 (red). Bottom panel represents quantification of relative area of NG2 positivity of CD31 positive vessels (5 fields/tumor, n = 3 tumors per group); **p < 0.01. c. Tumors were measured using calipers and volume estimated using the formula (((L + W)/2)^3)/2. d. Tumor mass was determined at the time of sacrifice (n = 10-11)CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 45 · Cited by 23

Metadata

Authors
Choudhary, M., Naczki, C., Chen, W., Barlow, K. D., Case, L. D., & Metheny-Barlow, L. J.
Affiliations
  • Duke University (US)
  • Wake Forest University Health Sciences (US)
  • Atrium Health Wake Forest Baptist (US)
Venue
BMC Cancer
Published
2015-05-23
Volume
15
Issue
1
Pages
427-427
ISSN
1471-2407 (ISSN-L)
OpenAlex
W1898767746
Cited by
23
References
45
Citations by year
2024: 4 · 2023: 1 · 2022: 3 · 2021: 2 · 2020: 3 · 2019: 2 · 2018: 2 · 2017: 4 · 2016: 2
FWCI
1.16
Type
journal article
Language
en
Open access
Locations
  • BMC Cancer (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (CA012197)
  • National Cancer Institute (R01CA138727, CA012197, CA138727, R21CA115829, CA115829, P30CA012197)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Connexins and lens biology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Keywords
connexin 43, gap junctions, tumor angiogenesis, endothelial cell proliferation, vascular smooth muscle cells, mural cells, endothelial quiescence, tumor-conditioned medium, breast cancer, MDA-MB-231 cells, tumor vascularization
MeSH terms
Animals, Breast Neoplasms, Cell Communication, Endothelium, Vascular, Humans, Neovascularization, Pathologic, RNA, Messenger, Culture Media, Conditioned, Gap Junctions, Connexin 43, Myocytes, Smooth Muscle, Endothelial Cells, Cell Line, Tumor, Cell Proliferation, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tumor-induced loss of mural Connexin 43 gap junction activity promotes endothelial proliferation. https://app.cochat.ai/papers/10.1186/s12885-015-1420-9
The paper
Choudhary, M., Naczki, C., Chen, W., Barlow, K. D., Case, L. D., & Metheny-Barlow, L. J. (2015). Tumor-induced loss of mural Connexin 43 gap junction activity promotes endothelial proliferation. BMC Cancer. https://doi.org/10.1186/s12885-015-1420-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.